Allspring Global Investments Holdings LLC has reduced their stake in
Labcorp Holdings Inc. The company is set to discuss various issues at the
44th Annual J.P. Morgan Healthcare Conference.
Labcorp significantly revised its growth outlook for its research unit due to the current funding crunch in the biotech sector. Despite this, the company has received a buy recommendation from
Bank of America Securities.
Pacer Advisors Inc. and
Voya Investment Management LLC have significant stock positions in Labcorp. The company recently announced the retirement of an executive. A close look at LH's valuation shows steady growth, and the company has declared a dividend of $0.72.
Labcorp's Q3 earnings surpassed estimates and continues to see growth in its diagnostics sector. The company's net margin has surged to 6.2%, reinforcing its bullish earnings turnaround narrative. Lastly, LH confirms the acquisition of select assets of
BioReference Health's Innovative Oncology and clinical testing services businesses.
Laboratory Corporation of America Holdings LH News Analytics from Tue, 11 Mar 2025 07:00:00 GMT to Wed, 31 Dec 2025 08:45:56 GMT -
Rating 2
- Innovation -4
- Information 7
- Rumor -6
